JP2022502056A5 - - Google Patents

Info

Publication number
JP2022502056A5
JP2022502056A5 JP2021517352A JP2021517352A JP2022502056A5 JP 2022502056 A5 JP2022502056 A5 JP 2022502056A5 JP 2021517352 A JP2021517352 A JP 2021517352A JP 2021517352 A JP2021517352 A JP 2021517352A JP 2022502056 A5 JP2022502056 A5 JP 2022502056A5
Authority
JP
Japan
Prior art keywords
tcr
amino acid
seq
exon
variable domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021517352A
Other languages
English (en)
Japanese (ja)
Other versions
JP7452880B2 (ja
JP2022502056A (ja
Filing date
Publication date
Priority claimed from CN201811123747.0A external-priority patent/CN110950949B/zh
Application filed filed Critical
Publication of JP2022502056A publication Critical patent/JP2022502056A/ja
Publication of JP2022502056A5 publication Critical patent/JP2022502056A5/ja
Application granted granted Critical
Publication of JP7452880B2 publication Critical patent/JP7452880B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021517352A 2018-09-26 2019-09-20 Ssx2抗原を識別するt細胞受容体 Active JP7452880B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201811123747.0A CN110950949B (zh) 2018-09-26 2018-09-26 一种识别ssx2抗原的t细胞受体
CN201811123747.0 2018-09-26
PCT/CN2019/107097 WO2020063488A1 (zh) 2018-09-26 2019-09-20 一种识别ssx2抗原的t细胞受体

Publications (3)

Publication Number Publication Date
JP2022502056A JP2022502056A (ja) 2022-01-11
JP2022502056A5 true JP2022502056A5 (cg-RX-API-DMAC7.html) 2022-09-29
JP7452880B2 JP7452880B2 (ja) 2024-03-19

Family

ID=69949278

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021517352A Active JP7452880B2 (ja) 2018-09-26 2019-09-20 Ssx2抗原を識別するt細胞受容体

Country Status (6)

Country Link
US (1) US11649270B2 (cg-RX-API-DMAC7.html)
EP (1) EP3858852B1 (cg-RX-API-DMAC7.html)
JP (1) JP7452880B2 (cg-RX-API-DMAC7.html)
CN (1) CN110950949B (cg-RX-API-DMAC7.html)
CA (1) CA3114451A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020063488A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114245807B (zh) 2019-06-25 2025-05-02 吉利德科学公司 Flt3l-fc融合蛋白和使用方法
CN112442119B (zh) * 2019-09-05 2023-02-24 香雪生命科学技术(广东)有限公司 一种识别ssx2的高亲和力t细胞受体
TWI890283B (zh) 2020-02-14 2025-07-11 美商基利科學股份有限公司 結合ccr8之抗體及融合蛋白及其用途
TWI815194B (zh) 2020-10-22 2023-09-11 美商基利科學股份有限公司 介白素2-Fc融合蛋白及使用方法
CN114524870A (zh) * 2020-11-23 2022-05-24 香雪生命科学技术(广东)有限公司 源自于ssx2抗原的短肽
WO2022245671A1 (en) 2021-05-18 2022-11-24 Gilead Sciences, Inc. Methods of using flt3l-fc fusion proteins
EP4423078A1 (en) 2021-10-28 2024-09-04 Gilead Sciences, Inc. Pyridizin-3(2h)-one derivatives
PE20241186A1 (es) 2021-10-29 2024-06-03 Gilead Sciences Inc Compuestos de cd73
CN118488948A (zh) 2021-12-22 2024-08-13 吉利德科学公司 Ikaros锌指家族降解剂及其用途
US20240124412A1 (en) 2021-12-22 2024-04-18 Gilead Sciences, Inc. Ikaros zinc finger family degraders and uses thereof
CA3248911A1 (en) 2022-01-28 2023-08-03 Gilead Sciences, Inc. POLY(ADENOSINE DIPHOSPHATE-RIBOSE) POLYMERASE 7 INHIBITORS
PL4245756T3 (pl) 2022-03-17 2025-02-17 Gilead Sciences, Inc. Środki degradujące palec cynkowy z rodziny ikaros i ich zastosowania
EP4511127A1 (en) 2022-04-21 2025-02-26 Gilead Sciences, Inc. Kras g12d modulating compounds
WO2024006929A1 (en) 2022-07-01 2024-01-04 Gilead Sciences, Inc. Cd73 compounds
EP4638436A1 (en) 2022-12-22 2025-10-29 Gilead Sciences, Inc. Prmt5 inhibitors and uses thereof
WO2024215754A1 (en) 2023-04-11 2024-10-17 Gilead Sciences, Inc. Kras modulating compounds
PE20260121A1 (es) 2023-04-21 2026-01-16 Gilead Sciences Inc Inhibidores de prmt5 y usos de los mismos
JP2026522894A (ja) 2023-06-30 2026-07-09 ギリアード サイエンシーズ, インコーポレイテッド Kras調節化合物
CN121568935A (zh) 2023-07-26 2026-02-24 吉利德科学公司 Parp7抑制剂
AU2024297978A1 (en) 2023-07-26 2026-02-05 Gilead Sciences, Inc. Parp7 inhibitors
EP4774280A1 (en) 2023-09-08 2026-07-15 Gilead Sciences, Inc. Kras g12d modulating compounds
US20250109147A1 (en) 2023-09-08 2025-04-03 Gilead Sciences, Inc. Kras g12d modulating compounds
WO2025096589A1 (en) 2023-11-03 2025-05-08 Gilead Sciences, Inc. Prmt5 inhibitors and uses thereof
US20250230168A1 (en) 2023-12-22 2025-07-17 Gilead Sciences, Inc. Azaspiro wrn inhibitors
WO2025245003A1 (en) 2024-05-21 2025-11-27 Gilead Sciences, Inc. Prmt5 inhibitors and uses thereof
US20260098049A1 (en) 2024-08-12 2026-04-09 Gilead Sciences, Inc. Kras modulating compounds
US20260130893A1 (en) 2024-10-21 2026-05-14 Gilead Sciences, Inc. Prmt5 inhibitors and uses thereof
WO2026136515A1 (en) 2024-12-19 2026-06-25 Gilead Sciences, Inc. Parp7 inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287756B1 (en) * 1997-05-05 2001-09-11 Ludwig Institute For Cancer Research Methods for determining presence of cancer in a sample by determining expression of an SSX gene
WO2003008537A2 (en) * 2001-04-06 2003-01-30 Mannkind Corporation Epitope sequences
MXPA04005382A (es) * 2001-11-07 2005-02-24 Mannkind Corp Vectores de expresion que codifican epitopes de antigenos asociados al objetivo y metodos para su diseno.
EP1545610A4 (en) * 2002-09-06 2006-11-08 Mannkind Corp EPITOPE SEQUENCES
US7511118B2 (en) 2005-06-17 2009-03-31 Mannkind Corporation PSMA peptide analogues
US9345748B2 (en) * 2010-09-21 2016-05-24 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Anti-SSX-2 T cell receptors and related materials and methods of use
CN102173056B (zh) * 2010-12-30 2014-09-03 联塑(杭州)机械有限公司 形成发泡产品的方法及其系统
JP6549564B2 (ja) 2013-06-26 2019-07-24 グアンドン シャンスエ ライフ サイエンス, リミテッド. 高安定性のt細胞受容体およびその製法と使用
GB201313377D0 (en) 2013-07-26 2013-09-11 Adaptimmune Ltd T cell receptors
JP6777841B2 (ja) * 2015-10-23 2020-10-28 国立大学法人金沢大学 細胞傷害性t細胞の作製方法
CN106519019B (zh) * 2015-11-06 2018-07-03 广东香雪精准医疗技术有限公司 识别prame抗原的tcr
CN108117596B (zh) * 2016-11-29 2023-08-29 香雪生命科学技术(广东)有限公司 针对ny-eso的高亲和力tcr
AU2018395397A1 (en) * 2017-12-28 2020-08-06 Gritstone Bio, Inc. Antigen-binding proteins targeting shared antigens
CN110343167B (zh) * 2018-04-03 2022-10-28 香雪生命科学技术(广东)有限公司 识别ssx2抗原短肽的t细胞受体
CA3133945A1 (en) * 2019-03-25 2020-10-01 University Health Network T cell receptors and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2021531834A5 (cg-RX-API-DMAC7.html)
HRP20230542T1 (hr) T stanični receptori
RU2016101711A (ru) Высокостабильный т-клеточный рецептор и способ его получения и применения
JP7452880B2 (ja) Ssx2抗原を識別するt細胞受容体
HRP20220865T1 (hr) T stanični receptori
JP2022115876A5 (cg-RX-API-DMAC7.html)
JP2023139070A5 (cg-RX-API-DMAC7.html)
US6416971B1 (en) Soluble single chain T cell receptors
JP2020501550A5 (cg-RX-API-DMAC7.html)
JP2018504092A5 (cg-RX-API-DMAC7.html)
JP2022527635A5 (cg-RX-API-DMAC7.html)
HRP20221021T1 (hr) T stanični receptori specifični za kompleks tumorskog antigena ny-eso-1 sa hla-a*02
IL308851B1 (en) T cell modulatory multimeric polypeptides and methods of using them
JP2022512994A5 (cg-RX-API-DMAC7.html)
ES2926511T3 (es) Anticuerpos anti-CLEVER-1 humanizados y utilización de los mismos
JP2015500811A5 (cg-RX-API-DMAC7.html)
RU2017144098A (ru) Гетеродимеризованный полипептид
RU2014135053A (ru) Иммуногены для вакцинации против вич
CN106632658B (zh) 识别ny-eso-1抗原短肽的tcr
CN106336457B (zh) 识别mage‑a3抗原短肽的t细胞受体
CN106478808B (zh) 识别ny-eso-1抗原短肽的t细胞受体
JP2024519614A5 (cg-RX-API-DMAC7.html)
JP2022502078A5 (cg-RX-API-DMAC7.html)
KR20220012227A (ko) Clec9a-기반 키메라 단백질 복합체
JP2017524675A5 (cg-RX-API-DMAC7.html)